Beta Drugs Limited — Investor Relations & Filings
Beta Drugs Limited specializes in the development, manufacture, and marketing of oncology formulations. The company provides a comprehensive portfolio of anti-cancer drugs across various therapeutic segments, including cytotoxic injectables, lyophilized products, tablets, and capsules. Its manufacturing capabilities encompass a wide range of oncology treatments such as chemotherapy agents and supportive care medications. The organization operates advanced production facilities designed to meet international quality standards, focusing on high-potency active pharmaceutical ingredients and finished dosage forms. The company serves diverse markets through its own branded products and contract manufacturing services, aiming to provide affordable and high-quality cancer care solutions. Its core competency lies in its specialized focus on the oncology niche and its integrated approach to pharmaceutical production.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Board Meeting — Other business matters | 2018-09-04 | English | |
| Board Meeting — Other business matters | 2018-08-31 | English | |
| Trading Window | 2018-08-27 | English | |
| Board Meeting — Other business matters | 2018-08-27 | English | |
| AGM/Book Closure | 2018-08-17 | English | |
| Outcome of Board Meeting | 2018-08-17 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2018
15 filings
| |||||
| 44044320 | Board Meeting — Other business matters | 2018-09-04 | English | ||
| 44044306 | Board Meeting — Other business matters | 2018-08-31 | English | ||
| 43537827 | Trading Window | 2018-08-27 | English | ||
| 44044314 | Board Meeting — Other business matters | 2018-08-27 | English | ||
| 43541471 | AGM/Book Closure | 2018-08-17 | English | ||
| 43542430 | Outcome of Board Meeting | 2018-08-17 | English | ||
| 44044727 | Board Meeting — Other business matters | 2018-08-08 | English | ||
| 43538343 | Updates | 2018-07-12 | English | ||
| 43550763 | Analysts/Institutional Investor Meet/Con. Call Updates | 2018-06-13 | English | ||
| 43571360 | Reply to Clarification- Financial results | 2018-05-22 | English | ||
| 43562572 | Analysts/Institutional Investor Meet/Con. Call Updates | 2018-05-16 | English | ||
| 43568199 | Statement of deviation(s) or variation(s) under Reg. 32 | 2018-05-08 | English | ||
| 43568272 | Outcome of Board Meeting | 2018-05-08 | English | ||
| 44049990 | Board Meeting — Financial Results | 2018-04-27 | English | ||
| 44050840 | Board Meeting — Financial Results | 2018-04-24 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Beta Drugs Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61112/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61112 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61112 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61112 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61112}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Beta Drugs Limited (id: 61112)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.